Senseonics Holdings (SENS) Prices 22.727M Share Offering at $1.10/Sh

Pre-Open Movers 07/17: (FRAN) (YTRA) (ORN) Higher; (NUS) (IMRN) (INO) (more...)

Today's Pre-Open Movers

Francesca's (NASDAQ: FRAN) 53.4% HIGHER; Cross River Capital Management filed a 13D, showing a 19.9% stake in the company.

Nu Skin Enterprises, Inc. (NYSE: NUS) 18.1% LOWER; announced estimated second-quarter results and updated its outlook for full-year... More

Senseonics Holdings (SENS) PT Lowered to $4 at Guggenheim

Guggenheim analyst Christopher Pasquale lowered the price target on Senseonics Holdings (NYSE: SENS) to $4.00 (from $5.00) while maintaining a Buy rating.

After-Hours Movers 07/16: (SGEN) (CTAS) (QCOM) Higher; (NUS) (IRMN) (SENS) (more...)

Today's After-Hours Movers

Nu Skin Enterprises, Inc. (NYSE: NUS) 18.1% LOWER; announced estimated second-quarter results and updated its outlook for full-year 2019. The company anticipates reporting second-quarter revenue between $622 and $623 million and earnings per share of $0.82 to $0.84. The company's revised revenue outlook for 2019 is $2.48 to $2.52 billion with a negative foreign currency impact of approximately 4 percent, and earnings per share of $3.20 to $3.35. (**Consensus sees Q2 EPS of $0.94 on revenue of $673.95 million and FY EPS of $3.95 on revneue of $2.77 billion)

Immuron Limited (NASDAQ: IMRN)... More

UPDATE: Senseonics Holdings (SENS) Reports Prelim. Q2 Expected Revenue Range of $4.4M to $4.7M

(Updated - July 16, 2019 4:13 PM EDT)

Senseonics Holdings, Inc. (NYSE: SENS) today announced preliminary financial results for the second quarter of 2019.

Unaudited, preliminary net revenue for the second quarter 2019 is expected to be in the range of $4.4 million to $4.7 million compared to $3.6 million in the second quarter of 2018. Second quarter 2019 international net revenue is expected to be in the range of $3.4 million to $3.6 million and United States net revenue is expected to be in the range of $1.0 million to $1.1 million. As of June 30, 2019, cash and... More

Senseonics Holdings (SENS) Announces $25M Public Offering of Common Stock

Senseonics Holdings, Inc. (Senseonics) (NYSE American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, today announced that it has commenced a registered underwritten public offering of $25.0... More

Senseonics Holdings (SENS) Announces Commencement of Convertible Notes Offering

Senseonics Holdings, Inc. (NYSE: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, today announced the commencement of an offering of $80.0 million aggregate principal amount of 5.25% convertible senior notes due 2025 (the 2025 notes) and the commencement of a consent solicitation in respect of its outstanding 5.25% convertible senior subordinated notes due 2023 (the 2023 notes).

Convertible Notes Offering

The 2025 notes will be unsecured, senior obligations of Senseonics. The 2025 notes will be convertible, at the option of the holders, into shares of... More